For laboratory and analytical research only. Not for use in humans or animals.

CJC-1295 (No DAC) + Ipamorelin Blend

An investigational blend of CJC-1295 No DAC and ipamorelin for investigation of GHRH and GHSR signalling. Available in vial format (5+5 MG). For laboratory research only.

Includes 1 × Bacwater 3 ml per vial

Price per item

€ 74,95 incl. VAT

Free shipping on orders over €100.

Shipping and returns · Available delivery options are shown at checkout.

Over CJC-1295 (No DAC) + Ipamorelin Blend

This format is offered as a research vial, with 5+5 MG as the stated strength. The product name, the selected format and the batch documentation together form the basis for comparing research materials. A stated quantity is not advice for use or dosage.

Wat is CJC-1295 (No DAC) + Ipamorelin Blend?

This blend combines the peptide presented as CJC-1295 No DAC with ipamorelin. The components are investigated in relation to different routes of growth hormone release.

The addition No DAC is essential when comparing literature. Research into long-acting, albumin-binding CJC-1295 does not directly support this No DAC blend.

What does the research focus on?

The area of ​​research includes pituitary signalling and the comparison of different receptor-dependent pathways. A combination must be assessed as its own research material.

  • GHRH-related signalling and the pathway by which ipamorelin is investigated.
  • Separate and combined responses in an appropriate research model.
  • Checking peptide identity, DAC status and component ratio.

Product specifications

Product CJC-1295 (No DAC) + Ipamorelin Blend
Format Research vial
Vermelde sterkte 5+5 MG
Onderzoeksgebied Growth hormone research
Storage Volgens de actuele batchdocumentatie
Intended use Laboratory and analytical research

Use in research

Use this material only as an experimental reagent within a documented laboratory or analytical protocol. Select the test method, model and working conditions using validated literature and product-specific technical documentation.

  • Check the selected strength and batch identity before starting the experiment.
  • Consult the current safety data sheet, certificate details and storage instructions.
  • Validate solvent compatibility, concentration, stability and controls for the selected model.
  • Document preparation, storage, handling and disposal within the laboratory workflow.

The product name alone does not establish a universal reconstitution or working protocol.

Frequently asked questions

Is this the same blend as Tesamorelin + Ipamorelin?

No. The first component is CJC-1295 No DAC and not tesamorelin. The description and specifications of a tesamorelin blend are therefore not interchangeable.

Wat betekent de aanduiding 5+5 MG?

The catalogue lists two component quantities. The available vial report #211784 reports measured content per component and does not provide a purity percentage for the blend.

What does the stated strength mean?

The catalogue mentions 5+5 MG. This designation describes the format offered and is not a concentration or recommended amount for an experiment. A measurement result from a report may deviate from the nominal label.

How should I store this product?

Follow the current storage information for the supplied batch and product format. Do not use a general storage temperature or shelf life from a comparable product as a substitute for its own documentation.

Research references

The CJC-1295 article discusses an albumin binding analog and is not proof of this No DAC implementation. The sources also do not certify the combined Novogin blend.

For laboratory and analytical research only. Not for use in humans or animals, consumption, cosmetic use or use as a food supplement. This research material is not offered as an approved medicine. No medical, dosing or injection advice is provided.

Strength

5+5 MG

COA status

Available

This register links substance documentation to the specified products, including vial and pen formats and their strength variants. The sample label describes the tested sample. Measurements belong to that sample and do not establish the content, device or delivered batch of every linked format. Check the batch number on the delivered product. A report does not establish suitability for human or animal use.

CJC-1295 (No DAC) + Ipamorelin Blend - 5+5 MG

Report available

Report number

211784

Batch number

2608028

Laboratory

Janoshik

Analysis date

2026-07-31

Sample label

5 mg + 5 mg

Format

Vial

Measured content

CJC-1295 No DAC: 4.75 mg; Ipamorelin: 4.27 mg

Documentation coverage

Linked products of the same substance, including their strength variants

Review

Not yet reviewed

Stock link for sampled variant

Current stock not confirmed

View original report

View all batch documentation

Check before ordering

01 / Check your selection

Check the product format, available strength and quantity before ordering.

02 / Review the documentation

Review the linked substance documentation and sample data. Check the product format, retail content and delivered batch separately.

03 / A question about this product?

Contact us and include the product name and batch number when requesting available documentation.

Continue browsing the catalogue